US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 13.300
  • -0.250-1.85%
Close May 31 16:00 ET
  • 13.490
  • +0.190+1.43%
Post 17:37 ET
480.53MMarket Cap-4130P/E (TTM)

UroGen Pharma Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
152.17%164.05M
37.02%136.97M
37.02%136.97M
53.70%147.42M
-57.67%47.3M
-52.32%65.05M
12.14%99.96M
12.14%99.96M
-9.70%95.91M
-7.68%111.74M
-Cash and cash equivalents
259.71%131.44M
71.46%95M
71.46%95M
315.90%119.31M
-75.06%20.13M
-65.33%36.54M
24.91%55.41M
24.91%55.41M
-48.16%28.69M
27.43%80.69M
-Short-term investments
14.35%32.61M
-5.81%41.97M
-5.81%41.97M
-58.18%28.11M
-12.48%27.17M
-8.21%28.51M
-0.50%44.56M
-0.50%44.56M
32.15%67.23M
-46.20%31.05M
Receivables
13.33%14.16M
21.56%15.44M
21.56%15.44M
36.25%12.85M
33.72%15.51M
31.52%12.49M
8.42%12.7M
8.42%12.7M
21.13%9.43M
21.90%11.6M
-Accounts receivable
13.33%14.16M
21.56%15.44M
21.56%15.44M
36.25%12.85M
33.72%15.51M
31.52%12.49M
8.42%12.7M
8.42%12.7M
21.13%9.43M
21.90%11.6M
Inventory
32.51%7.24M
31.17%5.67M
31.17%5.67M
2.88%5M
-1.17%4.99M
14.93%5.47M
-10.49%4.33M
-10.49%4.33M
27.68%4.86M
47.53%5.05M
Restricted cash
1.11%823K
0.98%821K
0.98%821K
0.62%817K
0.62%816K
48.00%814K
-33.69%813K
-33.69%813K
-33.77%812K
-33.80%811K
Other current assets
-13.63%10.49M
-7.39%10.28M
-7.39%10.28M
51.59%16.04M
21.95%12.72M
30.95%12.15M
48.49%11.1M
48.49%11.1M
73.07%10.58M
96.55%10.43M
Total current assets
105.02%196.76M
31.25%169.19M
31.25%169.19M
49.78%182.12M
-41.75%81.33M
-40.21%95.97M
12.69%128.91M
12.69%128.91M
-2.83%121.59M
-0.62%139.62M
Non current assets
Net PPE
-41.46%2.01M
-37.05%2.36M
-37.05%2.36M
-34.81%2.73M
-18.92%3.02M
26.08%3.43M
19.13%3.75M
19.13%3.75M
23.23%4.19M
1.83%3.72M
-Gross PPE
-10.52%6.08M
-8.51%6.31M
-8.51%6.31M
-8.58%6.49M
3.06%6.59M
31.69%6.8M
28.40%6.9M
28.40%6.9M
31.24%7.1M
17.36%6.4M
-Accumulated depreciation
-21.03%-4.08M
-25.46%-3.95M
-25.46%-3.95M
-29.10%-3.76M
-33.64%-3.58M
-37.94%-3.37M
-41.51%-3.15M
-41.51%-3.15M
-44.76%-2.91M
-48.94%-2.68M
Investments and advances
-95.27%481K
--4.5M
--4.5M
--6.51M
1,084.25%7.97M
1,408.16%10.17M
--0
--0
--0
-91.88%673K
Other non current assets
-60.87%1.32M
-23.62%2.26M
-23.62%2.26M
-15.55%2.28M
43.24%3.04M
88.52%3.38M
93.16%2.96M
93.16%2.96M
34.97%2.69M
60.11%2.12M
Total non current assets
-77.54%3.81M
35.95%9.13M
35.95%9.13M
67.32%11.51M
115.25%14.03M
227.12%16.98M
25.32%6.71M
25.32%6.71M
-27.31%6.88M
-50.89%6.52M
Total assets
77.57%200.57M
31.48%178.31M
31.48%178.31M
50.72%193.63M
-34.75%95.36M
-31.84%112.95M
13.26%135.62M
13.26%135.62M
-4.55%128.47M
-4.96%146.14M
Liabilities
Current liabilities
Payables
-10.18%6.26M
17.86%6.51M
17.86%6.51M
58.78%4.04M
89.62%4.66M
64.57%6.97M
-4.48%5.53M
-4.48%5.53M
-37.32%2.55M
-49.13%2.46M
-accounts payable
-10.18%6.26M
17.86%6.51M
17.86%6.51M
58.78%4.04M
89.62%4.66M
64.57%6.97M
-4.48%5.53M
-4.48%5.53M
-37.32%2.55M
-49.13%2.46M
Current accrued expenses
17.09%11.9M
46.21%10.02M
46.21%10.02M
47.44%10.04M
89.73%11.74M
78.22%10.16M
8.55%6.86M
8.55%6.86M
-2.73%6.81M
12.30%6.19M
Other current liabilities
0.38%3.2M
17.83%3.86M
17.83%3.86M
17.73%3.55M
22.80%3.64M
-20.55%3.19M
-1.62%3.28M
-1.62%3.28M
33.07%3.02M
52.76%2.97M
Current liabilities
4.38%26.34M
30.51%31.21M
30.51%31.21M
35.73%25.79M
48.36%26.77M
32.18%25.23M
6.86%23.92M
6.86%23.92M
-4.07%19M
-5.33%18.04M
Non current liabilities
Long term debt and capital lease obligation
-1.12%98.23M
0.27%99.4M
0.27%99.4M
35.02%99.54M
36.85%99.51M
39.78%99.34M
24,805.28%99.12M
24,805.28%99.12M
11,868.51%73.73M
7,786.23%72.71M
-Long term debt
-0.36%97.59M
1.04%98.55M
1.04%98.55M
37.08%98.52M
38.06%98.3M
38.34%97.94M
--97.54M
--97.54M
--71.87M
--71.2M
-Long term capital lease obligation
-54.60%637K
-46.78%844K
-46.78%844K
-44.72%1.03M
-20.20%1.21M
406.50%1.4M
298.49%1.59M
298.49%1.59M
201.30%1.86M
64.32%1.52M
Derivative product liabilities
10.83%112.95M
10.92%109.72M
10.92%109.72M
11.52%107.28M
11.82%104.51M
13.51%101.91M
15.41%98.92M
15.41%98.92M
20.35%96.19M
24.94%93.46M
Total non current liabilities
4.94%214.37M
5.59%212.31M
5.59%212.31M
21.46%209.84M
22.49%207.03M
24.79%204.27M
126.03%201.06M
126.03%201.06M
107.49%172.76M
115.47%169.01M
Total liabilities
4.88%240.71M
8.24%243.52M
8.24%243.52M
22.88%235.63M
24.99%233.8M
25.56%229.51M
102.08%224.98M
102.08%224.98M
86.05%191.76M
91.86%187.05M
Shareholders'equity
Share capital
54.69%99K
41.27%89K
41.27%89K
33.33%84K
3.23%64K
3.23%64K
3.28%63K
3.28%63K
3.28%63K
1.64%62K
-common stock
54.69%99K
41.27%89K
41.27%89K
33.33%84K
3.23%64K
3.23%64K
3.28%63K
3.28%63K
3.28%63K
1.64%62K
Retained earnings
-17.18%-711.63M
-17.72%-679.35M
-17.72%-679.35M
-19.17%-653.33M
-20.87%-631.45M
-22.51%-607.32M
-23.49%-577.1M
-23.49%-577.1M
-24.92%-548.24M
-27.83%-522.4M
Paid-in capital
36.82%671.44M
25.88%614.04M
25.88%614.04M
26.05%611.39M
2.41%493.11M
2.53%490.74M
2.54%487.79M
2.54%487.79M
3.13%485.04M
3.58%481.49M
Gains losses not affecting retained earnings
17.78%-37K
111.21%12K
111.21%12K
13.55%-134K
-175.00%-154K
34.78%-45K
-328.00%-107K
-328.00%-107K
-3,975.00%-155K
-224.44%-56K
Total stockholders'equity
65.57%-40.13M
27.02%-65.21M
27.02%-65.21M
33.65%-41.99M
-238.36%-138.43M
-582.64%-116.55M
-1,162.18%-89.36M
-1,162.18%-89.36M
-300.67%-63.29M
-172.71%-40.91M
Total equity
65.57%-40.13M
27.02%-65.21M
27.02%-65.21M
33.65%-41.99M
-238.36%-138.43M
-582.64%-116.55M
-1,162.18%-89.36M
-1,162.18%-89.36M
-300.67%-63.29M
-172.71%-40.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 152.17%164.05M37.02%136.97M37.02%136.97M53.70%147.42M-57.67%47.3M-52.32%65.05M12.14%99.96M12.14%99.96M-9.70%95.91M-7.68%111.74M
-Cash and cash equivalents 259.71%131.44M71.46%95M71.46%95M315.90%119.31M-75.06%20.13M-65.33%36.54M24.91%55.41M24.91%55.41M-48.16%28.69M27.43%80.69M
-Short-term investments 14.35%32.61M-5.81%41.97M-5.81%41.97M-58.18%28.11M-12.48%27.17M-8.21%28.51M-0.50%44.56M-0.50%44.56M32.15%67.23M-46.20%31.05M
Receivables 13.33%14.16M21.56%15.44M21.56%15.44M36.25%12.85M33.72%15.51M31.52%12.49M8.42%12.7M8.42%12.7M21.13%9.43M21.90%11.6M
-Accounts receivable 13.33%14.16M21.56%15.44M21.56%15.44M36.25%12.85M33.72%15.51M31.52%12.49M8.42%12.7M8.42%12.7M21.13%9.43M21.90%11.6M
Inventory 32.51%7.24M31.17%5.67M31.17%5.67M2.88%5M-1.17%4.99M14.93%5.47M-10.49%4.33M-10.49%4.33M27.68%4.86M47.53%5.05M
Restricted cash 1.11%823K0.98%821K0.98%821K0.62%817K0.62%816K48.00%814K-33.69%813K-33.69%813K-33.77%812K-33.80%811K
Other current assets -13.63%10.49M-7.39%10.28M-7.39%10.28M51.59%16.04M21.95%12.72M30.95%12.15M48.49%11.1M48.49%11.1M73.07%10.58M96.55%10.43M
Total current assets 105.02%196.76M31.25%169.19M31.25%169.19M49.78%182.12M-41.75%81.33M-40.21%95.97M12.69%128.91M12.69%128.91M-2.83%121.59M-0.62%139.62M
Non current assets
Net PPE -41.46%2.01M-37.05%2.36M-37.05%2.36M-34.81%2.73M-18.92%3.02M26.08%3.43M19.13%3.75M19.13%3.75M23.23%4.19M1.83%3.72M
-Gross PPE -10.52%6.08M-8.51%6.31M-8.51%6.31M-8.58%6.49M3.06%6.59M31.69%6.8M28.40%6.9M28.40%6.9M31.24%7.1M17.36%6.4M
-Accumulated depreciation -21.03%-4.08M-25.46%-3.95M-25.46%-3.95M-29.10%-3.76M-33.64%-3.58M-37.94%-3.37M-41.51%-3.15M-41.51%-3.15M-44.76%-2.91M-48.94%-2.68M
Investments and advances -95.27%481K--4.5M--4.5M--6.51M1,084.25%7.97M1,408.16%10.17M--0--0--0-91.88%673K
Other non current assets -60.87%1.32M-23.62%2.26M-23.62%2.26M-15.55%2.28M43.24%3.04M88.52%3.38M93.16%2.96M93.16%2.96M34.97%2.69M60.11%2.12M
Total non current assets -77.54%3.81M35.95%9.13M35.95%9.13M67.32%11.51M115.25%14.03M227.12%16.98M25.32%6.71M25.32%6.71M-27.31%6.88M-50.89%6.52M
Total assets 77.57%200.57M31.48%178.31M31.48%178.31M50.72%193.63M-34.75%95.36M-31.84%112.95M13.26%135.62M13.26%135.62M-4.55%128.47M-4.96%146.14M
Liabilities
Current liabilities
Payables -10.18%6.26M17.86%6.51M17.86%6.51M58.78%4.04M89.62%4.66M64.57%6.97M-4.48%5.53M-4.48%5.53M-37.32%2.55M-49.13%2.46M
-accounts payable -10.18%6.26M17.86%6.51M17.86%6.51M58.78%4.04M89.62%4.66M64.57%6.97M-4.48%5.53M-4.48%5.53M-37.32%2.55M-49.13%2.46M
Current accrued expenses 17.09%11.9M46.21%10.02M46.21%10.02M47.44%10.04M89.73%11.74M78.22%10.16M8.55%6.86M8.55%6.86M-2.73%6.81M12.30%6.19M
Other current liabilities 0.38%3.2M17.83%3.86M17.83%3.86M17.73%3.55M22.80%3.64M-20.55%3.19M-1.62%3.28M-1.62%3.28M33.07%3.02M52.76%2.97M
Current liabilities 4.38%26.34M30.51%31.21M30.51%31.21M35.73%25.79M48.36%26.77M32.18%25.23M6.86%23.92M6.86%23.92M-4.07%19M-5.33%18.04M
Non current liabilities
Long term debt and capital lease obligation -1.12%98.23M0.27%99.4M0.27%99.4M35.02%99.54M36.85%99.51M39.78%99.34M24,805.28%99.12M24,805.28%99.12M11,868.51%73.73M7,786.23%72.71M
-Long term debt -0.36%97.59M1.04%98.55M1.04%98.55M37.08%98.52M38.06%98.3M38.34%97.94M--97.54M--97.54M--71.87M--71.2M
-Long term capital lease obligation -54.60%637K-46.78%844K-46.78%844K-44.72%1.03M-20.20%1.21M406.50%1.4M298.49%1.59M298.49%1.59M201.30%1.86M64.32%1.52M
Derivative product liabilities 10.83%112.95M10.92%109.72M10.92%109.72M11.52%107.28M11.82%104.51M13.51%101.91M15.41%98.92M15.41%98.92M20.35%96.19M24.94%93.46M
Total non current liabilities 4.94%214.37M5.59%212.31M5.59%212.31M21.46%209.84M22.49%207.03M24.79%204.27M126.03%201.06M126.03%201.06M107.49%172.76M115.47%169.01M
Total liabilities 4.88%240.71M8.24%243.52M8.24%243.52M22.88%235.63M24.99%233.8M25.56%229.51M102.08%224.98M102.08%224.98M86.05%191.76M91.86%187.05M
Shareholders'equity
Share capital 54.69%99K41.27%89K41.27%89K33.33%84K3.23%64K3.23%64K3.28%63K3.28%63K3.28%63K1.64%62K
-common stock 54.69%99K41.27%89K41.27%89K33.33%84K3.23%64K3.23%64K3.28%63K3.28%63K3.28%63K1.64%62K
Retained earnings -17.18%-711.63M-17.72%-679.35M-17.72%-679.35M-19.17%-653.33M-20.87%-631.45M-22.51%-607.32M-23.49%-577.1M-23.49%-577.1M-24.92%-548.24M-27.83%-522.4M
Paid-in capital 36.82%671.44M25.88%614.04M25.88%614.04M26.05%611.39M2.41%493.11M2.53%490.74M2.54%487.79M2.54%487.79M3.13%485.04M3.58%481.49M
Gains losses not affecting retained earnings 17.78%-37K111.21%12K111.21%12K13.55%-134K-175.00%-154K34.78%-45K-328.00%-107K-328.00%-107K-3,975.00%-155K-224.44%-56K
Total stockholders'equity 65.57%-40.13M27.02%-65.21M27.02%-65.21M33.65%-41.99M-238.36%-138.43M-582.64%-116.55M-1,162.18%-89.36M-1,162.18%-89.36M-300.67%-63.29M-172.71%-40.91M
Total equity 65.57%-40.13M27.02%-65.21M27.02%-65.21M33.65%-41.99M-238.36%-138.43M-582.64%-116.55M-1,162.18%-89.36M-1,162.18%-89.36M-300.67%-63.29M-172.71%-40.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg